| Product NDC: | 0409-3378 |
| Proprietary Name: | Piperacillin and Tazobactam |
| Non Proprietary Name: | Piperacillin and Tazobactam |
| Active Ingredient(s): | 3; .375 g/1; g/1 & nbsp; Piperacillin and Tazobactam |
| Administration Route(s): | INTRAVENOUS; PARENTERAL |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0409-3378 |
| Labeler Name: | Hospira, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065363 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101021 |
| Package NDC: | 0409-3378-51 |
| Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (0409-3378-51) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
| NDC Code | 0409-3378-51 |
| Proprietary Name | Piperacillin and Tazobactam |
| Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (0409-3378-51) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
| Product NDC | 0409-3378 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Piperacillin and Tazobactam |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS; PARENTERAL |
| Start Marketing Date | 20101021 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc |
| Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
| Strength Number | 3; .375 |
| Strength Unit | g/1; g/1 |
| Pharmaceutical Classes | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |